HRS-8364
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 04, 2026
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
(clinicaltrials.gov)
- P1/2 | N=282 | Recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
March 04, 2026
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
(clinicaltrials.gov)
- P1/2 | N=282 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1/2 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1